Message from the void: MRD analysis from ctDNA.
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-04-901181
Abstract: In this issue of Blood , Nakamura et al demonstrate that circulating tumor DNA (ctDNA) in the serum can be used for minimal residual disease (MRD) assessment in acute myeloid leukemia (AML) and myelodysplastic syndrome… read more here.
Keywords: analysis ctdna; ctdna; mrd; mrd analysis ... See more keywords